Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 2/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1040195 | 1.00 | HTT (0.39) | HTTMAPK1RAB9ANQO2PTGS1 | |
| SCHEMBL1039562 | 0.76 | HTT (0.42) | HTTMAPK1RAB9ANQO2KDM4E | |
| SCHEMBL4151009 | 0.76 | HTT (0.42) | HTTMAPK1RAB9ANQO2KDM4E | |
| SCHEMBL9734139 | 0.75 | MAPT (0.48) | HTTRAB9ANQO2MEN1LMNA | |
| SCHEMBL9734131 | 0.75 | MAPT (0.48) | HTTRAB9ANQO2MEN1LMNA | |
| SCHEMBL4506296 | 0.71 | NFE2L2 (0.46) | RAB9AMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL4364965 | 0.71 | NFE2L2 (0.46) | RAB9AMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL12486822 | 0.67 | NQO2 (0.47) | RAB9ANQO2PTGS1PTGS2MEN1 | |
| SCHEMBL9977621 | 0.67 | TRPA1 (0.42) | RAB9ANQO2PTGS1PTGS2LMNA | |
| SCHEMBL9977558 | 0.67 | TRPA1 (0.42) | RAB9ANQO2PTGS1PTGS2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090197929-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Agents Containing Said Compounds | BASF SE (DE) | 2009-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197929-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Agents Containing Said Compounds | CBR3, PPOX, CBR1 | HTT 3905/4885MAPK1 2890/4885RAB9A 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.